Please login to the form below

Not currently logged in
Email:
Password:

Brukinsa

This page shows the latest Brukinsa news and features for those working in and with pharma, biotech and healthcare.

BeiGene and InnoRNA join to research novel mRNA therapies

BeiGene and InnoRNA join to research novel mRNA therapies

Also in June, the company announced that its BTK inhibitor Brukinsa (zanubrutinib) was approved by the ministry of Health in Kuwait, the National Health Regulatory Authority in Bahrain and the Ministry

Latest news

More from news
Approximately 5 fully matching, plus 4 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Medscape Education Global

Medscape delivers dynamic, innovative education to optimize learner engagement and patient outcomes worldwide....

Latest intelligence

Box 1
Strategic commitment
...
KOL Ambassador Program & Podcast Creation: A Customer Story
...
Animation: Living With
The journey from the patient's perspective...